生命科学资讯
生物技术与制药领域的最新动态
Roche's return to RNA continues with $1.7B deal for Sanegene program
Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative
China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again
Spring Health acquires Alma, expanding insurance reach in virtual mental health
三家大公司关闭马萨诸塞州设施；裁员将影响约250名员工——CBS新闻
3 major companies closing Massachusetts facilities; layoffs to affect about 250 workers - CBS News
Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPT
FDA rejects Aquestive's allergy drug over packaging issues
Biggest gainers and losers for Jan. 26-30, 2026
FDA opens submissions for PreCheck program to speed up US factory builds
PacBio sells short-read DNA sequencing assets to Illumina for $48.1m - Investing.com
Illumina buys SomaLogic in bid to expand proteomics reach - The Pharma Letter
SanegeneBio licenses RNAi candidate to Genentech for $200M upfront
Pacific Biosciences of California Signs Asset Purchase Agreement With Illumina Cambridge - TradingView
Thermo Fisher Scientific风投部门迎来Massey加盟 - 全球风险投资
Thermo Fisher Scientific’s venture arm brings Massey onboard - Global Venturing
Foundations Investment Advisors LLC Takes Position in 10x Genomics $TXG - MarketBeat
GSK walks away from pioneering Wave RNA editing drug
Arjuna Capital减持赛默飞世尔科技公司$TMO股份 - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Lessened by Arjuna Capital - MarketBeat